Plunkett Research Online: HilleVax Inc

HILLEVAX INC (HLVX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused.....


HILLEVAX INC

Ticker: HLVX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 617 213-5054
Fax:
Address: 321 Harrison Ave.
Boston, MA 02118 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Robert HershbergCEO/Chairman of the Board/Co-Founder/Director/President
Shane MaltbieCFO/Chief Accounting Officer/Vice President, Divisional
See More
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture